Cytomegalovirus Prophylaxis and Graft Outcome in Solid Organ Transplantation: A Collaborative Transplant Study Report

This publication has 37 references indexed in Scilit:

• Locally derived cytokines and upregulation of MHC class II genes in allografts
  The Journal of Heart and Lung Transplantation, 2002
• Editorial
  Transplant Infectious Disease, 2001
• A PROSPECTIVE STUDY OF THE NATURAL COURSE OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN RENAL ALLOGRAFT RECIPIENTS1
  Transplantation, 2000
• Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis
  Transplant Infectious Disease, 2000
• Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
  New England Journal of Medicine, 1999
• Management of Cytomegalovirus Infection after Solid-Organ or Stem-Cell Transplantation
  Drugs, 1998
• Prognostic Factors in Metastatic Malignant Melanoma
  Oncology, 1997
• Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression
  Kidney International, 1996
• OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver Transplantation
  The Journal of Infectious Diseases, 1995
• A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal Allografts
  New England Journal of Medicine, 1989